Document is current
Any future updates will be listed below
-
Authors
Fazazi, Mohamed Reda
Doss, Prenitha Mercy Ignatius Arokia
Pereira, Resel
Fudge, Neva
Regmi, Aryan
Joly-Beauparlant, Charles
Akbar, Irshad
Yeola, Asmita Pradeep
Mailhot, Benoit
Baillargeon, Joanie
Grenier, Philippe
Bertrand, Nicolas
Lacroix, Steve
Droit, Arnaud https://orcid.org/0000-0001-7922-790X
Moore, Craig S. https://orcid.org/0000-0003-3333-435X
Rojas, Olga L. https://orcid.org/0000-0003-2300-1658
Rangachari, Manu https://orcid.org/0000-0002-7065-3803
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-178109-2021)
University Health Network (410014711)
- License Information
-
More Information
Article History
Received: 28 September 2023
Accepted: 30 May 2024
First Online: 26 June 2024
Competing interests
: M.R. held a research contract with Remedy Pharmaceuticals (2019-2021), with funds paid to the CHU de Québec and has conducted educational activities for Novartis Canada. These activities are unrelated to the work in this manuscript. The remaining authors declare no competing interests.
